MRK

Merck & Co Inc

Healthcare


Presented:04/18/2018
Price:$58.92
Cap:$159.97B
Current Price:$111.53
Cap:$282.71B

Presented

Date04/18/2018
Price$58.92
Market Cap$159.97B
Ent Value$168.92B
P/E Ratio68.51x
Book Value$12.73
Div Yield3.26%
Shares O/S2,715.00M
Ave Daily Vol12,708,191
Short Int0.74%

Current

Price$111.53
Market Cap$282.71B
Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as vaccines, which it sells to veterinarians, distributors, and animal producers. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Publicly traded companies mentioned herein: Bristol-Myers Squibb Co (BMY), Eli Lilly and Co (LLY), Merck & Co Inc (MRK), Zoetis Inc (ZTS)

Highlights

The presenter is long shares of Merck (MRK), seeing an impending product cycle driven by its oncology product Keytruda that would drive earnings growth and multiple expansion. He models $5.00 in 2019 EPS, for a $75 price target on 15x P/E, or 25% upside from current levels.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.